EU Demands Pfizer Offload Infliximab Biosimilar In Hospira Buy

The EU Commission is backing Pfizer Inc.'s planned purchase of US-based generics firm Hospira Inc. provided the big pharma divest some sterile injectable drugs as well as its own biosimilar version of Johnson & Johnson and Merck & Co.'s Remicade (infliximab) which is currently under development.